{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:26:00Z","timestamp":1790961960002,"version":"4.1.0"},"reference-count":194,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104076"],"award-info":[{"award-number":["82104076"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473851"],"award-info":[{"award-number":["82473851"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3501905"],"award-info":[{"award-number":["2022YFC3501905"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["22QB1400700"],"award-info":[{"award-number":["22QB1400700"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["22S21902400"],"award-info":[{"award-number":["22S21902400"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["2060302"],"award-info":[{"award-number":["2060302"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.apsb.2025.04.002","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T19:43:45Z","timestamp":1743968625000},"page":"2845-2866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Nanomedicine-driven tumor glucose metabolic reprogramming for enhanced cancer immunotherapy"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8682-2380","authenticated-orcid":false,"given":"Chenwei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4487-2791","authenticated-orcid":false,"given":"Junjie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingmei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoran","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4525-9422","authenticated-orcid":false,"given":"Guangji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.04.002_bib1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.002_bib2","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2025.04.002_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-022-01247-x","article-title":"Cancer vaccines as promising immuno-therapeutics: platforms and current progress","volume":"15","author":"Liu","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2025.04.002_bib4","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy\u2014current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2025.04.002_bib5","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/d41573-024-00094-4","article-title":"The changing landscape of cancer cell therapies: clinical trials and real-world data","volume":"23","author":"Saez-Iba\u00f1ez","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2025.04.002_bib6","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/s41556-022-01002-x","article-title":"Metabolic communication in the tumour-immune microenvironment","volume":"24","author":"Kao","year":"2022","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2025.04.002_bib7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.apsb.2025.04.002_bib8","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","article-title":"Targeting the Warburg effect: a revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer","volume":"14","author":"Liao","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.04.002_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41423-021-00727-3","article-title":"The therapeutic implications of immunosuppressive tumor aerobic glycolysis","volume":"19","author":"Reinfeld","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.apsb.2025.04.002_bib10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","article-title":"Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy","volume":"78","author":"Bader","year":"2020","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2025.04.002_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1152\/physrev.00055.2009","article-title":"Biology of human sodium glucose transporters","volume":"91","author":"Wright","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.apsb.2025.04.002_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cytogfr.2017.04.003","article-title":"Dysfunctional T cell metabolism in the tumor microenvironment","volume":"35","author":"Beckermann","year":"2017","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.apsb.2025.04.002_bib13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fimmu.2018.00353","article-title":"Targeting tumor metabolism: a new challenge to improve immunotherapy","volume":"9","author":"Kouidhi","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2025.04.002_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121168","article-title":"Mitochondrial-targeting nanoprodrugs to mutually reinforce metabolic inhibition and autophagy for combating resistant cancer","volume":"278","author":"Sun","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.04.002_bib15","article-title":"Dual-targeted novel temozolomide nanocapsules encapsulating siPKM2 inhibit aerobic glycolysis to sensitize glioblastoma to chemotherapy","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.04.002_bib16","article-title":"Synchronous interventions of glucose and mitochondrial metabolisms for antitumor bioenergetic therapy","volume":"35","author":"Li","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.04.002_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.canlet.2014.09.003","article-title":"2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy","volume":"355","author":"Zhang","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2025.04.002_bib18","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1172\/JCI69589","article-title":"Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function","volume":"123","author":"Sukumar","year":"2013","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2025.04.002_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.actbio.2023.05.043","article-title":"Overcoming tumor microenvironment obstacles: current approaches for boosting nanodrug delivery","volume":"166","author":"Wang","year":"2023","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2025.04.002_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bcp.2014.07.019","article-title":"Heterogeneity of glycolysis in cancers and therapeutic opportunities","volume":"92","author":"Warmoes","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2025.04.002_bib21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumour microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.002_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40164-022-00277-y","article-title":"Heterogeneity of the tumor immune microenvironment and its clinical relevance","volume":"11","author":"Jia","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.apsb.2025.04.002_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s42255-020-0195-8","article-title":"Identifying strategies to target the metabolic flexibility of tumours","volume":"2","author":"M\u00e9ndez-Lucas","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib24","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","article-title":"Cancer cell metabolism and antitumour immunity","volume":"24","author":"De Martino","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2025.04.002_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.7150\/thno.80687","article-title":"Multifunctional metal-organic framework (MOF)-based nanoplatforms for cancer therapy: from single to combination therapy","volume":"13","author":"Yang","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.04.002_bib26","first-page":"3358","article-title":"Polysaccharide-based nanomedicines for cancer immunotherapy: a review","volume":"6","author":"Zeng","year":"2021","journal-title":"Bioact Mater"},{"key":"10.1016\/j.apsb.2025.04.002_bib27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.002_bib28","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1016\/j.apsb.2022.11.001","article-title":"Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy","volume":"12","author":"Xu","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.04.002_bib29","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.7150\/thno.100036","article-title":"Harnessing glucose metabolism with nanomedicine for cancer treatment","volume":"14","author":"Wang","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.04.002_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.01.068","article-title":"Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy","volume":"51","author":"Xu","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.04.002_bib31","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.7150\/thno.49577","article-title":"The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy","volume":"10","author":"Shi","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.04.002_bib32","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/s41563-020-0755-z","article-title":"The dose threshold for nanoparticle tumour delivery","volume":"19","author":"Ouyang","year":"2020","journal-title":"Nat Mater"},{"key":"10.1016\/j.apsb.2025.04.002_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115884","article-title":"Multifunctional nano MOF drug delivery platform in combination therapy","volume":"261","author":"Ma","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.04.002_bib34","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1038\/s41467-023-40270-5","article-title":"Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy","volume":"14","author":"Lee","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.04.002_bib35","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1038\/s41467-022-31799-y","article-title":"Engineered biomimetic nanoparticles achieve targeted delivery and efficient metabolism-based synergistic therapy against glioblastoma","volume":"13","author":"Lu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.04.002_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s42255-020-0172-2","article-title":"We need to talk about the Warburg effect","volume":"2","author":"DeBerardinis","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib37","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1038\/s41467-021-26180-4","article-title":"DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.04.002_bib38","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2353\/ajpath.2009.080596","article-title":"GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis","volume":"174","author":"Amann","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apsb.2025.04.002_bib39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/CCO.0b013e328356da72","article-title":"Glucose transporters in cancer metabolism","volume":"24","author":"Adekola","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.apsb.2025.04.002_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","article-title":"The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function","volume":"20","author":"Macintyre","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib41","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3389\/fimmu.2019.02278","article-title":"NK cell metabolism and tumor microenvironment","volume":"10","author":"Terr\u00e9n","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2025.04.002_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-022-01322-3","article-title":"Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity","volume":"15","author":"Yan","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2025.04.002_bib43","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","article-title":"Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma","volume":"57","author":"De Leo","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2025.04.002_bib44","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.ccell.2022.08.012","article-title":"Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance","volume":"40","author":"Shi","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2025.04.002_bib45","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","article-title":"Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1","volume":"35","author":"Wu","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib46","doi-asserted-by":"crossref","first-page":"12867","DOI":"10.1073\/pnas.0503603102","article-title":"Glucose transporter 1 expression identifies a population of cycling CD4+ CD8+ human thymocytes with high CXCR4-induced chemotaxis","volume":"102","author":"Swainson","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.04.002_bib47","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/s42255-023-00913-9","article-title":"The glucose transporter 2 regulates CD8+ T cell function via environment sensing","volume":"5","author":"Fu","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib48","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.apsb.2021.01.012","article-title":"The reversed intra- and extracellular pH in tumors as a unified strategy to chemotherapeutic delivery using targeted nanocarriers","volume":"11","author":"P\u00e9rez-Herrero","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.04.002_bib49","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.1158\/0008-5472.CAN-11-1457","article-title":"Lactate: a metabolic key player in cancer","volume":"71","author":"Hirschhaeuser","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2025.04.002_bib50","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.gendis.2022.10.006","article-title":"The function and mechanism of lactate and lactylation in tumor metabolism and microenvironment","volume":"10","author":"Zhang","year":"2023","journal-title":"Genes Dis"},{"key":"10.1016\/j.apsb.2025.04.002_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semcancer.2016.12.003","article-title":"Value of pH regulators in the diagnosis, prognosis and treatment of cancer","volume":"43","author":"Granja","year":"2017","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2025.04.002_bib52","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3389\/fonc.2019.01143","article-title":"Lactate in the regulation of tumor microenvironment and therapeutic approaches","volume":"9","author":"de la Cruz-L\u00f3pez","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.apsb.2025.04.002_bib53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.32348","article-title":"Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack","volume":"77","author":"Fang","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2025.04.002_bib54","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","article-title":"Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments","volume":"40","author":"Kumagai","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2025.04.002_bib55","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.immuni.2024.01.019","article-title":"Lactate modulates RNA splicing to promote CTLA-4 expression in tumor-infiltrating regulatory T cells","volume":"57","author":"Ding","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2025.04.002_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1620","article-title":"Unlocking the potential of T-cell metabolism reprogramming: advancing single-cell approaches for precision immunotherapy in tumour immunity","volume":"14","author":"Huang","year":"2024","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.apsb.2025.04.002_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2023.01.007","article-title":"Targeting monocarboxylate transporters (MCTs) in cancer: how close are we to the clinics?","volume":"90","author":"Singh","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2025.04.002_bib58","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.002_bib59","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cmet.2020.03.001","article-title":"Why Warburg works: lactate controls immune evasion through GPR81","volume":"31","author":"Lund\u00f8","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib60","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1038\/s44318-024-00110-8","article-title":"PKM2 functions as a histidine kinase to phosphorylate PGAM1 and increase glycolysis shunts in cancer","volume":"43","author":"Wang","year":"2024","journal-title":"EMBO J"},{"key":"10.1016\/j.apsb.2025.04.002_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2021.11.004","article-title":"Microbial regulation of hexokinase 2 links mitochondrial metabolism and cell death in colitis","volume":"33","author":"Hinrichsen","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2022.08.002","article-title":"Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of I\u03baB\u03b1","volume":"34","author":"Guo","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib63","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/s41467-024-45712-2","article-title":"HKDC1 promotes tumor immune evasion in hepatocellular carcinoma by coupling cytoskeleton to STAT1 activation and PD-L1 expression","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.04.002_bib64","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s42255-022-00642-5","article-title":"HK1 from hepatic stellate cell-derived extracellular vesicles promotes progression of hepatocellular carcinoma","volume":"4","author":"Chen","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib65","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature14405","article-title":"Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations","volume":"523","author":"Webb","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.002_bib66","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrc3110","article-title":"Dysregulated pH: a perfect storm for cancer progression","volume":"11","author":"Webb","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2025.04.002_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2018.03.018","article-title":"EGFR-phosphorylated platelet isoform of phosphofructokinase 1 promotes PI3K activation","volume":"70","author":"Lee","year":"2018","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2025.04.002_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003093","article-title":"PI3K\u03b1 inhibitor CYH33 triggers antitumor immunity in murine breast cancer by activating CD8+T cells and promoting fatty acid metabolism","volume":"9","author":"Sun","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.apsb.2025.04.002_bib69","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12943-024-01978-0","article-title":"A novel pan-PI3K inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activation","volume":"23","author":"Peng","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apsb.2025.04.002_bib70","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/jcp.30536","article-title":"Multiple functions of pyruvate kinase M2 in various cell types","volume":"237","author":"Lee","year":"2022","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.apsb.2025.04.002_bib71","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.biocel.2010.02.005","article-title":"Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells","volume":"43","author":"Mazurek","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.apsb.2025.04.002_bib72","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41388-021-02133-5","article-title":"Tumor-associated macrophages promote PD-L1 expression in tumor cells by regulating PKM2 nuclear translocation in pancreatic ductal adenocarcinoma","volume":"41","author":"Xia","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2025.04.002_bib73","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3389\/fimmu.2017.01300","article-title":"Pyruvate kinase M2 is required for the expression of the immune checkpoint PD-L1 in immune cells and tumors","volume":"8","author":"Palsson-McDermott","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2025.04.002_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2020.05.004","article-title":"Ectosomal PKM2 promotes HCC by inducing macrophage differentiation and remodeling the tumor microenvironment","volume":"78","author":"Hou","year":"2020","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2025.04.002_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2022.02.028","article-title":"Hexokinase 1 cellular localization regulates the metabolic fate of glucose","volume":"82","author":"De Jesus","year":"2022","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2025.04.002_bib76","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s42255-020-0211-z","article-title":"Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism","volume":"2","author":"Aregger","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2023.12.003","article-title":"Metabolic switch regulates lineage plasticity and induces synthetic lethality in triple-negative breast cancer","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib78","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/s41467-022-29137-3","article-title":"Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion","volume":"13","author":"Jiang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.04.002_bib79","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s42255-020-0195-8","article-title":"Identifying strategies to target the metabolic flexibility of tumours","volume":"2","author":"M\u00e9ndez-Lucas","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib80","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1021\/acs.jmedchem.2c01505","article-title":"Discovery of the first lactate dehydrogenase proteolysis targeting chimera degrader for the treatment of pancreatic cancer","volume":"66","author":"Sun","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.04.002_bib81","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1002\/cam4.1820","article-title":"Lactate dehydrogenase A: a key player in carcinogenesis and potential target in cancer therapy","volume":"7","author":"Feng","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.apsb.2025.04.002_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2014.12.035","article-title":"Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer","volume":"358","author":"Augoff","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2025.04.002_bib83","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.abb2683","article-title":"Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity","volume":"371","author":"Xu","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.04.002_bib84","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib85","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","article-title":"Lactate metabolism in human health and disease","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2025.04.002_bib86","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2025.04.002_bib87","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41586-023-05939-3","article-title":"Lactate regulates cell cycle by remodelling the anaphase promoting complex","volume":"616","author":"Liu","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.002_bib88","article-title":"Lactate modulates cellular metabolism through histone lactylation-mediated gene expression in non-small cell lung cancer","volume":"11","author":"Jiang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.apsb.2025.04.002_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114957","article-title":"H3K9 lactylation in malignant cells facilitates CD8+ T cell dysfunction and poor immunotherapy response","volume":"43","author":"Wang","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2025.04.002_bib90","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2025.04.002_bib91","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib92","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ijc.26410","article-title":"Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK\/c-Jun activation","volume":"131","author":"Mendler","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.apsb.2025.04.002_bib93","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.it.2022.10.005","article-title":"Lactic acid and lactate: revisiting the physiological roles in the tumor microenvironment","volume":"43","author":"Apostolova","year":"2022","journal-title":"Trends Immunol"},{"key":"10.1016\/j.apsb.2025.04.002_bib94","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1038\/s41467-022-32521-8","article-title":"Lactate increases stemness of CD8+ T cells to augment anti-tumor immunity","volume":"13","author":"Feng","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.04.002_bib95","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","article-title":"When worlds collide: Th17 and Treg cells in cancer and autoimmunity","volume":"15","author":"Knochelmann","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.apsb.2025.04.002_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110986","article-title":"Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-\u03b2 signaling in regulatory T cells","volume":"39","author":"Gu","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2025.04.002_bib98","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-immunol-061020-053707","article-title":"Dendritic cells revisited","volume":"39","author":"Cabeza-Cabrerizo","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.apsb.2025.04.002_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2017.08.012","article-title":"Cell-intrinsic glycogen metabolism supports early glycolytic reprogramming required for dendritic cell immune responses","volume":"26","author":"Thwe","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.613492","article-title":"Metabolism of dendritic cells in tumor microenvironment: for immunotherapy","volume":"12","author":"Peng","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2025.04.002_bib101","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41388-020-1216-5","article-title":"The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment","volume":"39","author":"Brown","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2025.04.002_bib102","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adi4191","article-title":"A lactate\u2013SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression","volume":"9","author":"Plebanek","year":"2024","journal-title":"Science Immunology"},{"key":"10.1016\/j.apsb.2025.04.002_bib103","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.immuni.2020.05.005","article-title":"Transcriptional networks driving dendritic cell differentiation and function","volume":"52","author":"Nutt","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2025.04.002_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.888313","article-title":"Plasticity of NK cells in cancer","volume":"13","author":"Corvino","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2025.04.002_bib105","article-title":"Lactate dehydrogenase A-dependent aerobic glycolysis promotes natural killer cell anti-viral and anti-tumor function","volume":"35","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2025.04.002_bib106","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.1901376116","article-title":"Enhanced oxidative phosphorylation in NKT cells is essential for their survival and function","volume":"116","author":"Kumar","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.04.002_bib107","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1158\/2326-6066.CIR-18-0481","article-title":"Lactate-mediated acidification of tumor microenvironment induces apoptosis of liver-resident NK cells in colorectal liver metastasis","volume":"7","author":"Harmon","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.apsb.2025.04.002_bib108","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apsb.2025.04.002_bib109","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","article-title":"Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells","volume":"191","author":"Husain","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2025.04.002_bib110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.apsb.2025.04.002_bib111","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2025.04.002_bib112","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12964-018-0262-x","article-title":"Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction","volume":"16","author":"Feng","year":"2018","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.apsb.2025.04.002_bib113","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1073\/pnas.1614035114","article-title":"Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis","volume":"114","author":"Chen","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.04.002_bib114","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3390\/cancers11070963","article-title":"Machilin A inhibits tumor growth and macrophage M2 polarization through the reduction of lactic acid","volume":"11","author":"Chung","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.apsb.2025.04.002_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.07.014","article-title":"Programing of an intravascular immune firewall by the gut microbiota protects against pathogen dissemination during infection","volume":"28","author":"McDonald","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.apsb.2025.04.002_bib116","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg2697","article-title":"D-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma","volume":"9","author":"Han","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2025.04.002_bib117","article-title":"Self-assembled carrier-free nanodrugs for starvation therapy-amplified photodynamic therapy of cancer","volume":"12","author":"Zhang","year":"2023","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.apsb.2025.04.002_bib118","doi-asserted-by":"crossref","first-page":"8735","DOI":"10.1021\/acs.nanolett.2c03608","article-title":"Interference of glucose bioavailability of tumor by engineered biohybrids for potentiating targeting and uptake of antitumor nanodrugs","volume":"22","author":"Wang","year":"2022","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2025.04.002_bib119","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jconrel.2022.05.049","article-title":"Injectable alginate hydrogels for synergistic tumor combination therapy through repolarization of tumor-associated macrophages","volume":"348","author":"Xiao","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.04.002_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102057","article-title":"ROS responsive nanoparticles mediated inhibition of monocarboxylic acid transporters to enhance chemoimmunotherapy by overcoming low immune response in osteosarcoma","volume":"54","author":"Han","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2025.04.002_bib121","article-title":"Lactate efflux inhibition by syrosingopine\/LOD co-loaded nanozyme for synergetic self-replenishing catalytic cancer therapy and immune microenvironment remodeling","volume":"10","author":"Wu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2025.04.002_bib122","article-title":"Tumor-targeted disruption of lactate transport with reactivity-reversible nanocatalysts to amplify oxidative damage","volume":"17","author":"Wang","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.apsb.2025.04.002_bib123","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1021\/acs.nanolett.1c03089","article-title":"GSH-responsive nanoprodrug to inhibit glycolysis and alleviate immunosuppression for cancer therapy","volume":"21","author":"Liu","year":"2021","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2025.04.002_bib124","article-title":"Enhancing apoptosome assembly via mito-biomimetic lipid nanocarrier for cancer therapy","volume":"33","author":"Han","year":"2023","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.apsb.2025.04.002_bib125","doi-asserted-by":"crossref","first-page":"14667","DOI":"10.1021\/acsnano.3c02428","article-title":"Metal-phenolic nanomedicines regulate T-cell antitumor function for sono-metabolic cancer therapy","volume":"17","author":"Yan","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.04.002_bib126","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1021\/acs.nanolett.8b04296","article-title":"Nanoenabled modulation of acidic tumor microenvironment reverses anergy of infiltrating T cells and potentiates anti-PD-1 therapy","volume":"19","author":"Zhang","year":"2019","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2025.04.002_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.134781","article-title":"Zinc-enriched nanosystem for dual glycolysis regulation and photothermal therapy to synergistically inhibit primary melanoma and lung metastasis","volume":"435","author":"Meng","year":"2022","journal-title":"Chem Eng J"},{"key":"10.1016\/j.apsb.2025.04.002_bib128","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.gendis.2022.10.006","article-title":"The function and mechanism of lactate and lactylation in tumor metabolism and microenvironment","volume":"10","author":"Zhang","year":"2023","journal-title":"Genes Dis"},{"key":"10.1016\/j.apsb.2025.04.002_bib129","first-page":"22054","article-title":"Openwork@dendritic mesoporous silica nanoparticles for lactate depletion and tumor microenvironment regulation","volume":"59","author":"Tang","year":"2020","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2025.04.002_bib130","first-page":"426","article-title":"Nanofactory for metabolic and chemodynamic therapy: pro-tumor lactate trapping and anti-tumor ROS transition","volume":"19","author":"He","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2025.04.002_bib131","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1021\/acs.chemrev.8b00672","article-title":"Nanozymes: classification, catalytic mechanisms, activity regulation, and applications","volume":"119","author":"Huang","year":"2019","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2025.04.002_bib132","article-title":"Benefits of an immunogenic personalized neoantigen nanovaccine in patients with high-risk gastric\/gastroesophageal junction cancer","volume":"11","author":"Yao","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2025.04.002_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101448","article-title":"Anti-alcoholism drug disulfiram for targeting glioma energy metabolism using BBB-penetrating delivery of fixed-dose combination","volume":"44","author":"Zhao","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2025.04.002_bib134","doi-asserted-by":"crossref","first-page":"20377","DOI":"10.1021\/acsnano.1c08689","article-title":"Macrophage membrane-camouflaged responsive polymer nanogels enable magnetic resonance imaging-guided chemotherapy\/chemodynamic therapy of orthotopic glioma","volume":"15","author":"Xiao","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.04.002_bib135","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh1261","article-title":"Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression","volume":"14","author":"Mao","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2025.04.002_bib136","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/s41551-020-0597-7","article-title":"Tumour sensitization via the extended intratumoural release of a STING agonist and camptothecin from a self-assembled hydrogel","volume":"4","author":"Wang","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.apsb.2025.04.002_bib137","article-title":"Self-assembling paclitaxel-mediated stimulation of tumor-associated macrophages for postoperative treatment of glioblastoma","volume":"120","author":"Wang","year":"2023","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.apsb.2025.04.002_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101722","article-title":"Reversing the negative effect of adenosine A1 receptor-targeted immunometabolism modulation on melanoma by a co-delivery nanomedicine for self-activation of anti-PD-L1 DNAzyme","volume":"48","author":"Guo","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2025.04.002_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120711","article-title":"Enhanced response to PD-L1 silencing by modulation of TME via balancing glucose metabolism and robust co-delivery of siRNA\/resveratrol with dual-responsive polyplexes","volume":"271","author":"Jia","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.04.002_bib140","first-page":"71","article-title":"The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo","volume":"65","author":"Maeda","year":"2013","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2025.04.002_bib141","first-page":"282","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2025.04.002_bib142","doi-asserted-by":"crossref","first-page":"50734","DOI":"10.1021\/acsami.0c14909","article-title":"Multifunctional nanoparticles boost cancer immunotherapy based on modulating the immunosuppressive tumor microenvironment","volume":"12","author":"Li","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2025.04.002_bib143","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s41565-024-01668-4","article-title":"Nanoparticles for inducing Gaucher disease-like damage in cancer cells","volume":"19","author":"Yue","year":"2024","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2025.04.002_bib144","doi-asserted-by":"crossref","first-page":"13826","DOI":"10.1021\/acsnano.1c05613","article-title":"Sequentially triggered bacterial outer membrane vesicles for macrophage metabolism modulation and tumor metastasis suppression","volume":"15","author":"Guo","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.04.002_bib145","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201903746","article-title":"Catalytically selective chemotherapy from tumor-metabolic generated lactic acid","volume":"15","author":"Tian","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.apsb.2025.04.002_bib146","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41573-019-0032-5","article-title":"Targeting metabolism to regulate immune responses in autoimmunity and cancer","volume":"18","author":"Patel","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2025.04.002_bib147","article-title":"Nanocatalytic anti-tumor immune regulation","volume":"63","author":"Li","year":"2024","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.apsb.2025.04.002_bib148","article-title":"Supramolecular prodrug hydrogelator as an immune booster for checkpoint blocker\u2013based immunotherapy","volume":"6","author":"Wang","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2025.04.002_bib149","article-title":"Insights into the effect of catalytic intratumoral lactate depletion on metabolic reprogramming and immune activation for antitumoral activity","volume":"10","author":"Zhao","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2025.04.002_bib150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12929-022-00859-2","article-title":"Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?","volume":"29","author":"Kuo","year":"2022","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.apsb.2025.04.002_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.102009","article-title":"Gemcitabine nano-prodrug reprograms intratumoral metabolism and alleviates immunosuppression for hepatocellular carcinoma therapy","volume":"53","author":"Wang","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2025.04.002_bib152","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the intersections between metabolism and cancer biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2025.04.002_bib153","doi-asserted-by":"crossref","first-page":"13461","DOI":"10.1021\/acsnano.3c01743","article-title":"A dual-mechanism based nutrient partitioning nanoregulator for enhanced immunotherapy against anti-PD-1 resistant tumors","volume":"17","author":"Zhang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.04.002_bib154","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1021\/acs.nanolett.2c05029","article-title":"Zinc-carnosine metallodrug network as dual metabolism inhibitor overcoming metabolic reprogramming for efficient cancer therapy","volume":"23","author":"Lei","year":"2023","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2025.04.002_bib155","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","article-title":"Metabolic programming and immune suppression in the tumor microenvironment","volume":"41","author":"Arner","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2025.04.002_bib156","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tibs.2018.10.011","article-title":"Lactate: a metabolic driver in the tumour landscape","volume":"44","author":"Ippolito","year":"2019","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.apsb.2025.04.002_bib157","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature24057","article-title":"Glucose feeds the TCA cycle via circulating lactate","volume":"551","author":"Hui","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.002_bib158","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/s41591-019-0592-2","article-title":"Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer","volume":"25","author":"Joshi","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.04.002_bib159","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1038\/s41467-019-11788-4","article-title":"Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry","volume":"10","author":"Huang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.04.002_bib160","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/2159-8290.CD-19-0680","article-title":"Single-cell transcriptome analysis reveals disease-defining T-cell subsets in the tumor microenvironment of classic hodgkin lymphoma","volume":"10","author":"Aoki","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2025.04.002_bib161","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","article-title":"Phenotype molding of stromal cells in the lung tumor microenvironment","volume":"24","author":"Lambrechts","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.04.002_bib162","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","article-title":"The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma","volume":"8","author":"Pavlides","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.apsb.2025.04.002_bib163","doi-asserted-by":"crossref","DOI":"10.1172\/JCI183366","article-title":"Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy","volume":"134","author":"Song","year":"2024","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2025.04.002_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101331","article-title":"Yeast@MOF bioreactor as a tumor metabolic symbiosis disruptor for the potent inhibition of metabolically heterogeneous tumors","volume":"42","author":"Wang","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2025.04.002_bib165","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148550","article-title":"Clinical development of metabolic inhibitors for oncology","volume":"132","author":"Lemberg","year":"2022","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2025.04.002_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103627","article-title":"Lactate in the tumour microenvironment: from immune modulation to therapy","volume":"73","author":"Wang","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.apsb.2025.04.002_bib167","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1021\/acsnano.8b00309","article-title":"Engineering of a nanosized biocatalyst for combined tumor starvation and low-temperature photothermal therapy","volume":"12","author":"Zhou","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.04.002_bib168","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13046-017-0580-7","article-title":"Silencing the Girdin gene enhances radio-sensitivity of hepatocellular carcinoma via suppression of glycolytic metabolism","volume":"36","author":"Yu","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.apsb.2025.04.002_bib169","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.apsb.2023.12.008","article-title":"Nano-formulated delivery of active ingredients from traditional Chinese herbal medicines for cancer immunotherapy","volume":"14","author":"Shang","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.04.002_bib170","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","article-title":"Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma","volume":"39","author":"Feng","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.apsb.2025.04.002_bib171","first-page":"1355","article-title":"SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma progression","volume":"44","author":"Zhang","year":"2020","journal-title":"Oncol Rep"},{"key":"10.1016\/j.apsb.2025.04.002_bib172","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jb\/mvz099","article-title":"miR-206 regulates non-small-cell lung cancer cell aerobic glycolysis by targeting hexokinase 2","volume":"167","author":"Jia","year":"2020","journal-title":"J Biochem"},{"key":"10.1016\/j.apsb.2025.04.002_bib173","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3390\/ijms21030937","article-title":"The pentose phosphate pathway and its involvement in cisplatin resistance","volume":"21","author":"Giacomini","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.04.002_bib174","first-page":"909","article-title":"Prodrug nanoparticles potentiate tumor chemo-immunometabolic therapy by disturbing oxidative stress","volume":"352","author":"Zhao","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.apsb.2025.04.002_bib175","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.7150\/thno.54227","article-title":"Recent advances in innovative strategies for enhanced cancer photodynamic therapy","volume":"11","author":"Hu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2025.04.002_bib176","doi-asserted-by":"crossref","first-page":"16715","DOI":"10.1021\/acsnano.3c03169","article-title":"Bifunctional cascading nanozymes based on carbon dots promotes photodynamic therapy by regulating hypoxia and glycolysis","volume":"17","author":"Luo","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.04.002_bib177","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mattod.2023.07.003","article-title":"Biomimetic multifunctional nanodrugs enable regulating abnormal tumor metabolism and amplifying PDT-induced immunotherapy for synergistically enhanced tumor ablation","volume":"68","author":"Liu","year":"2023","journal-title":"Mater Today"},{"key":"10.1016\/j.apsb.2025.04.002_bib178","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1039\/C8CS00618K","article-title":"Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer","volume":"48","author":"Liu","year":"2019","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apsb.2025.04.002_bib179","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400819","article-title":"A multifunctional nanoreactor-induced dual inhibition of HSP70 strategy for enhancing mild photothermal\/chemodynamic synergistic tumor therapy","volume":"13","author":"Wu","year":"2024","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.apsb.2025.04.002_bib180","article-title":"Reprogramming the tumor microenvironment through second-near-infrared-window photothermal genome editing of PD-L1 mediated by supramolecular gold nanorods for enhanced cancer immunotherapy","volume":"33","author":"Tang","year":"2021","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.04.002_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102186","article-title":"Degradable CRISPR\/Cas9 nanosystem activated by NIR-II light targets genome editing of PD-L1 and metabolic modulation for enhanced antitumor immunity","volume":"55","author":"Zhao","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2025.04.002_bib182","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.radonc.2006.08.012","article-title":"Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice","volume":"81","author":"Quennet","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.apsb.2025.04.002_bib183","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s12885-017-3402-6","article-title":"Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors","volume":"17","author":"Leung","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.apsb.2025.04.002_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101366","article-title":"Radiotherapy: brightness and darkness in the era of immunotherapy","volume":"19","author":"Zhai","year":"2022","journal-title":"Transl Oncol"},{"key":"10.1016\/j.apsb.2025.04.002_bib185","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41571-023-00782-x","article-title":"Emerging evidence for adapting radiotherapy to immunotherapy","volume":"20","author":"Galluzzi","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.apsb.2025.04.002_bib186","doi-asserted-by":"crossref","first-page":"13884","DOI":"10.1021\/acsnano.2c02688","article-title":"Chemical modulation of glucose metabolism with a fluorinated CaCO3 nanoregulator can potentiate radiotherapy by programming antitumor immunity","volume":"16","author":"Dong","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2025.04.002_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.150130","article-title":"Stimulus-responsive nanomedicine mediated by metabolic intervention mechanisms to amplify redox anticancer therapy","volume":"486","author":"Shen","year":"2024","journal-title":"Chem Eng J"},{"key":"10.1016\/j.apsb.2025.04.002_bib188","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.aquatox.2016.09.013","article-title":"Zinc oxide nanoparticles induce oxidative DNA damage and ROS-triggered mitochondria-mediated apoptosis in zebrafish embryos","volume":"180","author":"Zhao","year":"2016","journal-title":"Aquat Toxicol"},{"key":"10.1016\/j.apsb.2025.04.002_bib189","doi-asserted-by":"crossref","first-page":"14267","DOI":"10.1002\/anie.201708573","article-title":"A redox modulatory Mn3 O4 nanozyme with multi-enzyme activity provides efficient cytoprotection to human cells in a Parkinson's disease model","volume":"56","author":"Singh","year":"2017","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.apsb.2025.04.002_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2022.128820","article-title":"Integrative proteomics and metabolomics approach to elucidate metabolic dysfunction induced by silica nanoparticles in hepatocytes","volume":"434","author":"Zhu","year":"2022","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.apsb.2025.04.002_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2023.07.001","article-title":"Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1","volume":"35","author":"Wu","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib192","article-title":"A phase I, dose-escalation, multi-center study of PFK-158 in patients with advanced solid malignancies explores a first-in-man inhbibitor of glycolysis","volume":"33","author":"Redman","year":"2015","journal-title":"J Clin Orthod"},{"key":"10.1016\/j.apsb.2025.04.002_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2023.07.001","article-title":"Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1","volume":"35","author":"Wu","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.04.002_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2019.02.001","article-title":"Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies","volume":"35","author":"Jiang","year":"2019","journal-title":"Cancer Cell"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525002217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525002217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:19:19Z","timestamp":1762604359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525002217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":194,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2211383525002217"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.04.002","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomedicine-driven tumor glucose metabolic reprogramming for enhanced cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}